Yilang
Cheng
abc,
Xu
Han
ab,
Junyou
Li
ab,
Yu
Zhou
*ab and
Hong
Liu
*abc
aState Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai, 201203, China. E-mail: zhouyu@simm.ac.cn; hliu@simm.ac.cn
bUniversity of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China
cSchool of Life Science and Technology, ShanghaiTech University, 100 Haike Road, Shanghai 201210, China
First published on 23rd October 2020
Correction for ‘A removable directing group-assisted Rh(III)-catalyzed direct C–H bond activation/annulation cascade to synthesize highly fused isoquinolines’ by Yilang Cheng et al., Org. Chem. Front., 2020, 7, 3186–3192, DOI: 10.1039/D0QO00786B.
The text “we serendipitously detected that the azomethine imine group could be used as a removable DG when treating aryl azomethine imines (1) with 4-diazoisochroman-3-imine (2) in the presence of a Rh(III)-complex catalyst, in which the highly fused isoquinoline scaffolds could be effectively and facilely constructed via a C–H activation and annulation cascade (Scheme 1d).” should read “we serendipitously detected that the azomethine imine group could be used as a removable DG when treating aryl azomethine imines (1) with 4-diazoisochroman-3-imine (2), an intriguing substrate for the synthesis of isochroman polycyclic scaffolds,1,2 in the presence of a Rh(III)-complex catalyst, in which the highly fused isoquinoline scaffolds could be effectively and facilely constructed via a C–H activation and annulation cascade (Scheme 1d).”
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © the Partner Organisations 2020 |